Lazard (LAZ)

• Market cap: $3.5B
• 1 day: -0.23%
• 5 days: 1.62%
• 1 month: -10.16%
• 3 months: -29.48%
• 6 months: -23.26%
• Year to date: -23.33%
• 1 year: 1.04%
• 5 years: 41.45%
• 10 years: -26.65%
• Sector: Financials
• Industry: Capital Markets

About: Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.

Employees: 3,263

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

245% more call options, than puts

Call options by funds: $19.4M | Put options by funds: $5.61M

96% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 27

40% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 81

7% more funds holding

Funds holding: 270 [Q3] → 288 (+18) [Q4]

6% more capital invested

Capital invested by funds: $3.93B [Q3] → $4.17B (+$242M) [Q4]

2.73% more ownership

Funds ownership: 69.18% [Q3] → 71.92% (+2.73%) [Q4]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $33 15% downside
• Avg. target: $45 16% upside
• High target: $55 41% upside

4 analyst ratings

• positive: 1 25%
• neutral: 2 50%
• negative: 1 25%

JMP Securities Devin Ryan 67% 1-year accuracy 4 / 6 met price target	41% upside $55	Market Outperform Reiterated	28 Apr 2025
Wells Fargo Michael Brown 39% 1-year accuracy 29 / 75 met price target	2% downside $38	Equal-Weight Maintained	8 Apr 2025
Morgan Stanley Ryan Kenny 18% 1-year accuracy 4 / 22 met price target	15% downside $33	Underweight Downgraded	7 Apr 2025
UBS Brennan Hawken 55% 1-year accuracy 18 / 33 met price target	39% upside $54	Neutral Maintained	3 Feb 2025